899 filings
Page 5 of 45
UPLOAD
ozp4t
9 Jul 19
Letter from SEC
12:00am
8-K
obtx82nf65shbh1h 62k
27 Jun 19
Advaxis Announces Increasing Focus on Neoantigen-Directed Immunotherapies and Closing of its Phase 3 AIM2CERV Study
4:30pm
8-K
nbq8ay385
10 Jun 19
Advaxis Reports Second Quarter Fiscal 2019 Financial Results and Provides Pipeline Update
5:28pm
8-K
qs13bhy ek
15 May 19
Other Events
10:00am
8-K
is3q0jyf5eq7b kf
13 May 19
Advaxis Announces Appointment of Dr. Robert Petit to Chair of Scientific Advisory Board and Departure as Chief Scientific Officer
4:30pm
8-K
o3b680j bwvo
15 Apr 19
Other Events
12:01pm
SC 13G
dvggn4kw
12 Apr 19
Advaxis, Inc.
10:22am
4
ux5yz 4hofurjn47
11 Apr 19
Advaxis / Andres Gutierrez ownership change
5:11pm
4
yxo1pivx4f slv
11 Apr 19
Advaxis / RONI APPEL ownership change
12:11pm
4
w5oceew
11 Apr 19
Advaxis / Molly Henderson ownership change
12:11pm
4
2xbi9whvs57iwo8074
10 Apr 19
Advaxis / Molly Henderson ownership change
9:12am
SC 13G
y0nfdblchnjk04pi6pr
9 Apr 19
Advaxis, Inc.
4:05pm
4
4k7gsdie gd1
8 Apr 19
Advaxis / Kenneth A Berlin ownership change
2:33pm
8-K
l5xr2a
5 Apr 19
Entry into a Material Definitive Agreement
4:05pm
424B5
4kt3cp4
3 Apr 19
Prospectus supplement for primary offering
5:23pm
SC 13G
md9r0vp6yfgeboll9
3 Apr 19
Advaxis, Inc.
10:34am
424B5
bh5t p1oy
2 Apr 19
Prospectus supplement for primary offering
5:19pm
8-K
zxdr6m cwa4muf
29 Mar 19
Material Modifications to Rights of Security Holders
4:00pm